Human red cell galactose 1-phosphate uridylyltransferase: effects of site-specific reagents on catalytic activity.
D001665:Binding Sites / Q000187:drug effects; D002729:Chloromercuribenzoates / Q000494:pharmacology*; D004047:Diethyl Pyrocarbonate / Q000494:pharmacology*; D004226:Dithioerythritol / Q000494:pharmacology; D004912:Erythrocytes / Q000201:enzymology*; D005561:Formates / Q000494:pharmacology*; D006801:Humans; D007461:Iodoacetates / Q000494:pharmacology*; D007700:Kinetics; D009713:Nucleotidyltransferases / Q000037:antagonists & inhibitors*; D005694:UTP-Hexose-1-Phosphate Uridylyltransferase / Q000037:antagonists & inhibitors* / Q000097:blood; D014531:Uridine Diphosphate Galactose / Q000494:pharmacology; D014532:Uridine Diphosphate Glucose / Q000494:pharmacology
D002729:Chloromercuribenzoates; D005561:Formates; D007461:Iodoacetates; D014531:Uridine Diphosphate Galactose; D004226:Dithioerythritol; D009713:Nucleotidyltransferases; D005694:UTP-Hexose-1-Phosphate Uridylyltransferase; D004047:Diethyl Pyrocarbonate; D014532:Uridine Diphosphate Glucose